Dihydropyridine Calcium Channel Blocker [EPC]

Dihydropyridine Calcium Channel Blocker [EPC] was reported 328392 times

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARDIOSPASM 407 0.7294
1 IMMUNISATION 261 0.6014
2 PALMOPLANTAR KERATODERMA 401 0.5531
3 GINGIVAL HYPERTROPHY 536 0.3531
4 DISTRIBUTIVE SHOCK 800 0.3529
5 NON-CARDIOGENIC PULMONARY OEDEMA 370 0.3497
6 VASOPLEGIA SYNDROME 567 0.3455
7 HYPERPARATHYROIDISM SECONDARY 669 0.2667
8 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 282 0.2655
9 NEPHROGENIC ANAEMIA 1194 0.2575
10 BRASH SYNDROME 308 0.2194
11 ATRIAL TACHYCARDIA 443 0.2108
12 BLOOD PRESSURE SYSTOLIC ABNORMAL 468 0.1892
13 PRURITUS GENITAL 440 0.1867
14 SUSPECTED SUICIDE 831 0.1771
15 BLOOD PRESSURE DIASTOLIC ABNORMAL 419 0.1646
16 CAROTID ARTERY OCCLUSION 529 0.1449
17 REBOUND ACID HYPERSECRETION 422 0.1394
18 END STAGE RENAL DISEASE 2500 0.1369
19 PHYSICAL DECONDITIONING 310 0.1203
20 SEDATION COMPLICATION 288 0.1128
21 TENSION HEADACHE 483 0.1122
22 SLEEP TERROR 465 0.1103
23 BLOOD PRESSURE INADEQUATELY CONTROLLED 624 0.1036
24 ATRIOVENTRICULAR BLOCK FIRST DEGREE 402 0.0926
25 SHOCK 2111 0.0917
26 BLOOD PRESSURE SYSTOLIC INCREASED 1761 0.0902
27 LEFT VENTRICULAR HYPERTROPHY 382 0.0892
28 CREATININE RENAL CLEARANCE DECREASED 355 0.0886
29 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 217 0.0877
30 DIASTOLIC DYSFUNCTION 266 0.0861
31 CHRONIC KIDNEY DISEASE 6405 0.0842
32 ORTHOSTATIC HYPOTENSION 1424 0.0817
33 HYPOMAGNESAEMIA 1137 0.0816
34 VASCULITIS 951 0.0816
35 BLOOD PRESSURE DIASTOLIC DECREASED 599 0.0811
36 METABOLIC ACIDOSIS 2503 0.0782
37 PERSONALITY DISORDER 204 0.0778
38 TUBULOINTERSTITIAL NEPHRITIS 1442 0.0769
39 CARDIOGENIC SHOCK 1103 0.0768
40 BREATH SOUNDS ABNORMAL 375 0.0760
41 HYPOPNOEA 263 0.0757
42 ACUTE KIDNEY INJURY 11589 0.0757
43 APLASTIC ANAEMIA 389 0.0744
44 SUBARACHNOID HAEMORRHAGE 753 0.0739
45 HYPERTENSIVE CRISIS 819 0.0735
46 LOW BIRTH WEIGHT BABY 584 0.0734
47 COMPLETED SUICIDE 6102 0.0732
48 HYPERKALAEMIA 2548 0.0726
49 ATRIOVENTRICULAR BLOCK COMPLETE 479 0.0715
50 RALES 414 0.0712
51 BRONCHIECTASIS 478 0.0709
52 POTENTIATING DRUG INTERACTION 231 0.0688
53 HAEMODYNAMIC INSTABILITY 516 0.0677
54 KIDNEY TRANSPLANT REJECTION 321 0.0668
55 FACIAL PAIN 597 0.0668
56 BLOOD PRESSURE DIASTOLIC INCREASED 307 0.0665
57 LACTIC ACIDOSIS 2123 0.0655
58 PROTEIN URINE PRESENT 326 0.0653
59 GINGIVAL SWELLING 288 0.0651
60 ANURIA 561 0.0651
61 BRADYCARDIA 3457 0.0651
62 OLIGURIA 402 0.0647
63 BLOOD PRESSURE FLUCTUATION 1545 0.0643
64 SINUS BRADYCARDIA 618 0.0639
65 BENIGN PROSTATIC HYPERPLASIA 330 0.0638
66 HYPONATRAEMIA 3595 0.0638
67 HYPERURICAEMIA 261 0.0634
68 BLOOD LACTIC ACID INCREASED 333 0.0632
69 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 205 0.0620
70 CAROTID ARTERY STENOSIS 216 0.0618
71 HYPOKALAEMIA 2837 0.0614
72 PRE-ECLAMPSIA 287 0.0603
73 LEFT VENTRICULAR FAILURE 207 0.0601
74 INTENTIONAL OVERDOSE 3838 0.0598
75 RENAL TUBULAR NECROSIS 586 0.0597
76 AORTIC STENOSIS 207 0.0594
77 GINGIVAL PAIN 470 0.0590
78 BLOOD PRESSURE SYSTOLIC DECREASED 263 0.0578
79 PEMPHIGOID 434 0.0575
80 GLOMERULAR FILTRATION RATE DECREASED 701 0.0570
81 HYPERVOLAEMIA 280 0.0566
82 NOCTURIA 684 0.0563
83 BODY TEMPERATURE DECREASED 542 0.0550
84 HYPOVOLAEMIA 322 0.0550
85 RHINITIS 441 0.0546
86 RENAL FUNCTION TEST ABNORMAL 253 0.0544
87 BLOOD URIC ACID INCREASED 313 0.0542
88 FOETAL GROWTH RESTRICTION 326 0.0536
89 RENAL INJURY 1587 0.0534
90 PROTEINURIA 1015 0.0533
91 BLOOD CREATININE INCREASED 3477 0.0532
92 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 217 0.0531
93 IRON DEFICIENCY 239 0.0531
94 BUNDLE BRANCH BLOCK LEFT 225 0.0530
95 CIRCULATORY COLLAPSE 903 0.0530
96 CARDIAC MURMUR 458 0.0529
97 HYPOTENSION 10592 0.0527
98 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 540 0.0525
99 OBSTRUCTIVE AIRWAYS DISORDER 585 0.0525
100 PREMATURE DELIVERY 837 0.0525
101 BLOOD CALCIUM DECREASED 590 0.0524
102 DYSPNOEA EXERTIONAL 1973 0.0523
103 URINE OUTPUT DECREASED 454 0.0519
104 HYPOCALCAEMIA 981 0.0518
105 PULSELESS ELECTRICAL ACTIVITY 216 0.0516
106 BLOOD PRESSURE INCREASED 7868 0.0514
107 BLOOD UREA INCREASED 859 0.0512
108 HYPOVOLAEMIC SHOCK 245 0.0511
109 BLOOD CREATINE INCREASED 225 0.0508
110 BLOOD MAGNESIUM DECREASED 435 0.0504
111 AORTIC VALVE INCOMPETENCE 214 0.0502
112 VENTRICULAR TACHYCARDIA 828 0.0501
113 ISCHAEMIA 230 0.0500
114 INTESTINAL ISCHAEMIA 275 0.0499
115 ANGIOEDEMA 2207 0.0498
116 RENAL FAILURE 6617 0.0498
117 DRUG INTERACTION 7848 0.0494
118 HEART RATE DECREASED 1737 0.0494
119 PULMONARY OEDEMA 2214 0.0494
120 GOUT 884 0.0492
121 RENAL IMPAIRMENT 4137 0.0492
122 ACIDOSIS 374 0.0489
123 RENAL FAILURE CHRONIC 375 0.0487
124 UPPER GASTROINTESTINAL HAEMORRHAGE 818 0.0486
125 CORONARY ARTERY STENOSIS 244 0.0485
126 HEMIPLEGIA 403 0.0484
127 ACUTE PULMONARY OEDEMA 269 0.0479
128 ARTERIAL OCCLUSIVE DISEASE 375 0.0477
129 BUNDLE BRANCH BLOCK RIGHT 219 0.0477
130 DRUG LEVEL INCREASED 788 0.0476
131 HYPERTENSION 10055 0.0474
132 RENAL CYST 376 0.0473
133 OEDEMA PERIPHERAL 5761 0.0472
134 NEPHROPATHY 441 0.0472
135 HYPERCALCAEMIA 583 0.0472
136 LIP SWELLING 1568 0.0470
137 CARDIAC FAILURE ACUTE 313 0.0469
138 HYPOXIA 1652 0.0469
139 ANGINA PECTORIS 1340 0.0467
140 TRANSIENT ISCHAEMIC ATTACK 1566 0.0464
141 SPRUE-LIKE ENTEROPATHY 228 0.0462
142 ACUTE MYOCARDIAL INFARCTION 1360 0.0461
143 NEPHROTIC SYNDROME 316 0.0461
144 HYPOTHERMIA 462 0.0456
145 TROPONIN INCREASED 347 0.0456
146 ATRIOVENTRICULAR BLOCK 352 0.0455
147 GANGRENE 273 0.0453
148 PAROSMIA 341 0.0451
149 MYOPATHY 390 0.0451
150 MITRAL VALVE INCOMPETENCE 511 0.0451
151 HYPERKERATOSIS 249 0.0451
152 ELECTROLYTE IMBALANCE 524 0.0451
153 BLOOD POTASSIUM INCREASED 730 0.0449
154 SWOLLEN TONGUE 1404 0.0449
155 SEROTONIN SYNDROME 861 0.0448
156 CARDIOMEGALY 544 0.0442
157 ABNORMAL LOSS OF WEIGHT 300 0.0440
158 TOXICITY TO VARIOUS AGENTS 7412 0.0439
159 MAJOR DEPRESSION 319 0.0436
160 HYPERLIPIDAEMIA 521 0.0436
161 PREMATURE BABY 1311 0.0435
162 RHABDOMYOLYSIS 1810 0.0434
163 POLYURIA 354 0.0432
164 HYPOPHOSPHATAEMIA 319 0.0431
165 ACUTE RESPIRATORY FAILURE 830 0.0431
166 SPUTUM DISCOLOURED 408 0.0430
167 CEREBRAL ISCHAEMIA 221 0.0429
168 FLUID OVERLOAD 625 0.0429
169 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 220 0.0429
170 NEUTROPENIC SEPSIS 306 0.0428
171 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 378 0.0427
172 GINGIVITIS 230 0.0426
173 ACUTE CORONARY SYNDROME 353 0.0426
174 HAIR DISORDER 351 0.0426
175 DIZZINESS POSTURAL 413 0.0425
176 HAIR COLOUR CHANGES 530 0.0425
177 PERIPHERAL SWELLING 6557 0.0425
178 GINGIVAL BLEEDING 580 0.0424
179 DIABETIC NEUROPATHY 210 0.0424
180 BLOOD POTASSIUM DECREASED 1267 0.0421
181 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 400 0.0419
182 ARTERIOSCLEROSIS CORONARY ARTERY 277 0.0418
183 RENAL FAILURE ACUTE 1768 0.0416
184 MICTURITION URGENCY 475 0.0415
185 MELAENA 914 0.0415
186 UROSEPSIS 383 0.0415
187 HAEMODIALYSIS 348 0.0414
188 ATRIAL FLUTTER 330 0.0413
189 ARTERIOSCLEROSIS 389 0.0413
190 OEDEMA 2233 0.0411
191 BLOOD PRESSURE ABNORMAL 817 0.0411
192 BLOOD SODIUM DECREASED 774 0.0410
193 HYPERGLYCAEMIA 1489 0.0408
194 JOINT SWELLING 4914 0.0407
195 ANGINA UNSTABLE 264 0.0406
196 BLOOD ALBUMIN DECREASED 322 0.0405
197 OXYGEN SATURATION DECREASED 2274 0.0404
198 LARGE INTESTINE POLYP 279 0.0402
199 ANOSMIA 581 0.0401
200 BASAL CELL CARCINOMA 626 0.0401
201 HYPOGLYCAEMIA 1944 0.0400
202 TRICUSPID VALVE INCOMPETENCE 317 0.0399
203 COLITIS ISCHAEMIC 269 0.0398
204 FULL BLOOD COUNT ABNORMAL 421 0.0398
205 GENERALISED OEDEMA 491 0.0396
206 HEMIPARESIS 670 0.0395
207 IRON DEFICIENCY ANAEMIA 365 0.0395
208 ELECTROCARDIOGRAM ABNORMAL 310 0.0395
209 LEUKOCYTOSIS 714 0.0394
210 PULMONARY HYPERTENSION 821 0.0394
211 CEREBRAL INFARCTION 962 0.0393
212 SPINAL OSTEOARTHRITIS 345 0.0392
213 SENSORY LOSS 315 0.0391
214 ATELECTASIS 378 0.0391
215 EXERCISE TOLERANCE DECREASED 225 0.0391
216 RESPIRATORY RATE INCREASED 347 0.0390
217 HYDRONEPHROSIS 291 0.0388
218 ATRIAL FIBRILLATION 3756 0.0385
219 HYPERCHOLESTEROLAEMIA 371 0.0384
220 POLYP 251 0.0383
221 ACUTE RESPIRATORY DISTRESS SYNDROME 674 0.0381
222 TRANSFUSION 397 0.0379
223 SUBDURAL HAEMATOMA 541 0.0378
224 LEFT VENTRICULAR DYSFUNCTION 253 0.0377
225 SKIN ULCER 975 0.0377
226 PLEURAL EFFUSION 2295 0.0377
227 DUODENAL ULCER 266 0.0377
228 DIABETES MELLITUS INADEQUATE CONTROL 666 0.0376
229 BLOOD PRESSURE DECREASED 2496 0.0375
230 MENTAL STATUS CHANGES 1043 0.0375
231 HIATUS HERNIA 486 0.0375
232 DEPRESSED LEVEL OF CONSCIOUSNESS 1480 0.0374
233 PRODUCTIVE COUGH 1778 0.0372
234 CORONARY ARTERY OCCLUSION 507 0.0369
235 BLOOD IRON DECREASED 436 0.0367
236 IMPAIRED QUALITY OF LIFE 526 0.0366
237 MYOCARDIAL ISCHAEMIA 416 0.0365
238 LOWER GASTROINTESTINAL HAEMORRHAGE 270 0.0365
239 HAEMATOCRIT DECREASED 724 0.0365
240 VENTRICULAR EXTRASYSTOLES 379 0.0365
241 TASTE DISORDER 739 0.0364
242 PERICARDITIS 612 0.0364
243 RED BLOOD CELL SEDIMENTATION RATE INCREASED 403 0.0364
244 GROIN PAIN 319 0.0363
245 NEPHROPATHY TOXIC 407 0.0362
246 ANGIOPATHY 203 0.0362
247 BOWEL MOVEMENT IRREGULARITY 276 0.0360
248 DIVERTICULUM 256 0.0360
249 TINNITUS 1654 0.0360
250 DIPLOPIA 935 0.0360
251 FAECES SOFT 260 0.0357
252 SYNCOPE 3575 0.0357
253 ELECTROCARDIOGRAM QT PROLONGED 1279 0.0355
254 FAECES DISCOLOURED 768 0.0354
255 DEHYDRATION 4717 0.0353
256 HAEMORRHAGIC STROKE 276 0.0353
257 FLANK PAIN 331 0.0353
258 AORTIC ANEURYSM 268 0.0352
259 WHEEZING 2088 0.0352
260 COORDINATION ABNORMAL 491 0.0352
261 SUICIDE ATTEMPT 2132 0.0351
262 MULTIPLE ORGAN DYSFUNCTION SYNDROME 989 0.0349
263 PERICARDIAL EFFUSION 807 0.0349
264 CONCOMITANT DISEASE AGGRAVATED 215 0.0348
265 ALTERED STATE OF CONSCIOUSNESS 754 0.0348
266 MUSCLE TWITCHING 802 0.0348
267 PULMONARY ARTERIAL HYPERTENSION 504 0.0347
268 CLOSTRIDIUM DIFFICILE COLITIS 368 0.0347
269 INTERNATIONAL NORMALISED RATIO INCREASED 988 0.0346
270 MYASTHENIA GRAVIS 279 0.0345
271 PSYCHOLOGICAL TRAUMA 298 0.0345
272 HAEMOGLOBIN DECREASED 3544 0.0345
273 OESOPHAGITIS 377 0.0345
274 DYSARTHRIA 1298 0.0344
275 PULMONARY CONGESTION 454 0.0344
276 SINUS CONGESTION 465 0.0344
277 EXTRASYSTOLES 240 0.0343
278 THROMBOTIC MICROANGIOPATHY 335 0.0343
279 CORONARY ARTERY DISEASE 1039 0.0343
280 PNEUMONIA ASPIRATION 857 0.0343
281 PROSTATIC SPECIFIC ANTIGEN INCREASED 471 0.0342
282 RECTAL HAEMORRHAGE 1466 0.0341
283 HEART RATE IRREGULAR 768 0.0340
284 TACHYPNOEA 462 0.0339
285 RESPIRATORY FAILURE 2477 0.0339
286 RIGHT VENTRICULAR FAILURE 238 0.0339
287 SLEEP APNOEA SYNDROME 648 0.0339
288 C-REACTIVE PROTEIN INCREASED 1234 0.0339
289 TOXIC EPIDERMAL NECROLYSIS 515 0.0339
290 HAEMATEMESIS 858 0.0338
291 HYPOALBUMINAEMIA 263 0.0338
292 EOSINOPHILIA 592 0.0337
293 PANCREATITIS ACUTE 759 0.0337
294 DIALYSIS 479 0.0337
295 PALPITATIONS 3943 0.0336
296 ISCHAEMIC STROKE 600 0.0336
297 ANAL INCONTINENCE 301 0.0334
298 VENTRICULAR FIBRILLATION 370 0.0333
299 DRUG ERUPTION 590 0.0333
300 PETECHIAE 347 0.0332
301 MYOSITIS 297 0.0331
302 PULMONARY MASS 493 0.0331
303 DELIRIUM 1148 0.0330
304 LETHARGY 1903 0.0330
305 FLUID RETENTION 1681 0.0330
306 PERIPHERAL COLDNESS 453 0.0330
307 OSTEOARTHRITIS 1397 0.0329
308 URINARY RETENTION 1098 0.0329
309 ERECTILE DYSFUNCTION 843 0.0328
310 HEPATIC STEATOSIS 609 0.0327
311 MOTOR DYSFUNCTION 333 0.0326
312 POLLAKIURIA 1361 0.0326
313 MUSCULAR WEAKNESS 3701 0.0325
314 RENAL DISORDER 1515 0.0325
315 IMPAIRED GASTRIC EMPTYING 443 0.0325
316 GASTROENTERITIS 473 0.0324
317 COGNITIVE DISORDER 1509 0.0323
318 GAMMA-GLUTAMYLTRANSFERASE INCREASED 716 0.0323
319 MUSCULOSKELETAL CHEST PAIN 500 0.0323
320 UPPER-AIRWAY COUGH SYNDROME 266 0.0323
321 BALANCE DISORDER 2785 0.0322
322 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1680 0.0322
323 BLOOD COUNT ABNORMAL 488 0.0322
324 BODY HEIGHT DECREASED 344 0.0321
325 BLOOD URINE PRESENT 610 0.0321
326 ORAL PAIN 719 0.0321
327 SHOCK HAEMORRHAGIC 261 0.0320
328 SINUS TACHYCARDIA 455 0.0320
329 HAEMATURIA 1096 0.0320
330 CONFUSIONAL STATE 5162 0.0319
331 GASTRIC ULCER 607 0.0319
332 CARDIAC ARREST 2630 0.0318
333 EMPHYSEMA 321 0.0318
334 VITAMIN D DECREASED 272 0.0318
335 NEUTROPHIL COUNT INCREASED 325 0.0317
336 ASCITES 931 0.0316
337 ANAEMIA 6038 0.0316
338 PNEUMONIA BACTERIAL 290 0.0316
339 RED BLOOD CELL COUNT DECREASED 903 0.0316
340 ADRENAL INSUFFICIENCY 383 0.0315
341 HAIR TEXTURE ABNORMAL 421 0.0314
342 CHOLESTASIS 604 0.0314
343 MOUTH HAEMORRHAGE 230 0.0313
344 CHEST PAIN 5797 0.0313
345 GASTROINTESTINAL HAEMORRHAGE 2611 0.0312
346 HYPOPHAGIA 798 0.0312
347 HALLUCINATION, VISUAL 659 0.0312
348 FALL 10378 0.0311
349 CARDIAC FAILURE 2502 0.0311
350 RESPIRATORY DISTRESS 858 0.0311
351 COVID-19 PNEUMONIA 367 0.0311
352 PARKINSONISM 303 0.0310
353 INTERSTITIAL LUNG DISEASE 1502 0.0310
354 GASTRITIS 815 0.0309
355 PURPURA 274 0.0309
356 DYSURIA 1139 0.0309
357 ECCHYMOSIS 212 0.0309
358 HAEMORRHOIDS 603 0.0309
359 URINARY INCONTINENCE 915 0.0309
360 BLOOD CREATINE PHOSPHOKINASE INCREASED 888 0.0308
361 PYELONEPHRITIS 267 0.0308
362 DECREASED APPETITE 7153 0.0308
363 UNRESPONSIVE TO STIMULI 790 0.0306
364 PRESYNCOPE 744 0.0306
365 DECREASED ACTIVITY 330 0.0306
366 HAEMATOMA 792 0.0305
367 ARTHRITIS 2391 0.0304
368 CONSTIPATION 6618 0.0303
369 SEASONAL ALLERGY 429 0.0303
370 HEART RATE INCREASED 2996 0.0302
371 GASTROOESOPHAGEAL REFLUX DISEASE 2433 0.0302
372 CELLULITIS 1523 0.0302
373 HOSPICE CARE 298 0.0301
374 SUPRAVENTRICULAR TACHYCARDIA 287 0.0299
375 DYSPNOEA 16960 0.0299
376 ILEUS 372 0.0299
377 LUNG INFILTRATION 264 0.0299
378 HEPATOMEGALY 293 0.0298
379 MOUTH ULCERATION 628 0.0298
380 PULMONARY FIBROSIS 570 0.0297
381 WHITE BLOOD CELL COUNT INCREASED 1140 0.0297
382 PAIN IN JAW 841 0.0297
383 CYSTITIS 945 0.0296
384 RASH PAPULAR 664 0.0296
385 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 230 0.0296
386 BLOOD ALKALINE PHOSPHATASE INCREASED 735 0.0296
387 EATING DISORDER 630 0.0296
388 PNEUMONIA 9563 0.0295
389 ENCEPHALOPATHY 725 0.0295
390 TACHYCARDIA 2618 0.0294
391 SMALL INTESTINAL OBSTRUCTION 362 0.0294
392 INTERVERTEBRAL DISC DEGENERATION 272 0.0294
393 SQUAMOUS CELL CARCINOMA 276 0.0293
394 HAEMOPTYSIS 815 0.0292
395 EPISTAXIS 2185 0.0292
396 BLOOD CALCIUM INCREASED 256 0.0292
397 BLOOD LACTATE DEHYDROGENASE INCREASED 462 0.0291
398 CARDIOTOXICITY 260 0.0291
399 INCREASED TENDENCY TO BRUISE 268 0.0291
400 MADAROSIS 338 0.0291
401 SECRETION DISCHARGE 364 0.0290
402 BACTERAEMIA 344 0.0290
403 APHASIA 875 0.0289
404 PLATELET COUNT INCREASED 377 0.0289
405 MUSCLE SPASTICITY 355 0.0289
406 HYPOTHYROIDISM 921 0.0288
407 CHROMATURIA 651 0.0288
408 HALLUCINATION 2169 0.0288
409 CHOLECYSTITIS 342 0.0287
410 DRY MOUTH 2326 0.0286
411 CATARACT 1706 0.0286
412 URINARY TRACT INFECTION 4883 0.0286
413 COUGH 8022 0.0286
414 CEREBRAL HAEMORRHAGE 1024 0.0286
415 HYPERTHYROIDISM 413 0.0285
416 AGRANULOCYTOSIS 530 0.0285
417 FREQUENT BOWEL MOVEMENTS 767 0.0284
418 FEELING COLD 790 0.0283
419 HYPOKINESIA 411 0.0283
420 ULCER 450 0.0283
421 HAEMATOCHEZIA 1561 0.0283
422 MYOCLONUS 337 0.0282
423 PELVIC FRACTURE 220 0.0282
424 ASTHENIA 10569 0.0281
425 PHARYNGEAL SWELLING 275 0.0281
426 SWELLING FACE 1823 0.0280
427 SPINAL COMPRESSION FRACTURE 231 0.0279
428 DISORIENTATION 1105 0.0279
429 EJECTION FRACTION DECREASED 433 0.0278
430 MEDICATION ERROR 1547 0.0278
431 CHEST DISCOMFORT 2848 0.0278
432 CARDIAC FAILURE CONGESTIVE 2233 0.0278
433 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1334 0.0277
434 DIZZINESS 13850 0.0277
435 DIARRHOEA 17906 0.0277
436 NEURALGIA 674 0.0277
437 DIVERTICULITIS 767 0.0277
438 AGEUSIA 690 0.0276
439 RESPIRATORY TRACT CONGESTION 439 0.0276
440 RASH MACULO-PAPULAR 614 0.0276
441 SPINAL PAIN 323 0.0275
442 RENAL PAIN 292 0.0275
443 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 641 0.0275
444 INTERNAL HAEMORRHAGE 314 0.0275
445 ARRHYTHMIA 1299 0.0274
446 THIRST 490 0.0274
447 SEPSIS 3058 0.0274
448 MUSCULOSKELETAL DISCOMFORT 471 0.0273
449 GLAUCOMA 527 0.0273
450 ASPARTATE AMINOTRANSFERASE INCREASED 1449 0.0273
451 POOR QUALITY SLEEP 585 0.0271
452 HEPATIC FUNCTION ABNORMAL 1013 0.0271
453 LOWER RESPIRATORY TRACT INFECTION 1234 0.0271
454 CONTUSION 2612 0.0271
455 MYALGIA 4606 0.0271
456 MUSCULOSKELETAL PAIN 1418 0.0270
457 CARDIO-RESPIRATORY ARREST 1131 0.0270
458 VERTIGO 1634 0.0268
459 WEIGHT DECREASED 7484 0.0268
460 ALANINE AMINOTRANSFERASE INCREASED 1645 0.0268
461 LIVER FUNCTION TEST ABNORMAL 779 0.0268
462 SCIATICA 427 0.0268
463 FLATULENCE 1518 0.0267
464 DRY THROAT 272 0.0267
465 HEAD INJURY 846 0.0267
466 PNEUMONITIS 727 0.0267
467 VITAMIN D DEFICIENCY 260 0.0266
468 SINUS DISORDER 527 0.0266
469 ANHEDONIA 699 0.0266
470 TENDERNESS 276 0.0265
471 RESPIRATORY TRACT INFECTION 689 0.0264
472 NERVE COMPRESSION 244 0.0264
473 EYE PRURITUS 888 0.0264
474 INTENTIONAL PRODUCT USE ISSUE 2313 0.0264
475 INCONTINENCE 279 0.0264
476 TORSADE DE POINTES 207 0.0264
477 LOCALISED INFECTION 637 0.0263
478 BLINDNESS 1072 0.0263
479 HAEMORRHAGE INTRACRANIAL 393 0.0263
480 PAIN IN EXTREMITY 7741 0.0262
481 ABDOMINAL PAIN 6106 0.0262
482 SKIN LESION 719 0.0262
483 DYSSTASIA 765 0.0262
484 FEBRILE NEUTROPENIA 1738 0.0262
485 MOBILITY DECREASED 1882 0.0262
486 APHTHOUS ULCER 203 0.0261
487 DECUBITUS ULCER 213 0.0261
488 CHOLELITHIASIS 857 0.0261
489 BLOOD THYROID STIMULATING HORMONE INCREASED 240 0.0261
490 BACK PAIN 6055 0.0260
491 ESCHERICHIA INFECTION 214 0.0260
492 ROTATOR CUFF SYNDROME 334 0.0260
493 PLATELET COUNT DECREASED 2768 0.0259
494 ASPIRATION 284 0.0259
495 MALNUTRITION 290 0.0259
496 BLISTER 1455 0.0259
497 ABDOMINAL DISCOMFORT 4329 0.0258
498 DRUG-INDUCED LIVER INJURY 808 0.0257
499 MUSCLE ATROPHY 326 0.0257
500 COAGULOPATHY 428 0.0257
501 JAUNDICE 691 0.0257
502 PALLOR 698 0.0256
503 INFUSION SITE ERYTHEMA 216 0.0256
504 TOXIC SKIN ERUPTION 258 0.0256
505 DYSPEPSIA 2516 0.0255
506 FULL BLOOD COUNT DECREASED 515 0.0255
507 GAIT DISTURBANCE 4882 0.0255
508 ABNORMAL FAECES 209 0.0255
509 LOSS OF CONSCIOUSNESS 3265 0.0255
510 BLOOD TEST ABNORMAL 358 0.0255
511 PAIN OF SKIN 686 0.0255
512 HEAD DISCOMFORT 451 0.0254
513 LIMB DISCOMFORT 788 0.0254
514 DISTURBANCE IN ATTENTION 1372 0.0254
515 ECONOMIC PROBLEM 385 0.0254
516 MUSCLE SPASMS 4661 0.0254
517 LOCAL SWELLING 443 0.0254
518 SKIN LACERATION 276 0.0254
519 DYSPHAGIA 2409 0.0254
520 RIB FRACTURE 522 0.0254
521 ATAXIA 300 0.0253
522 FATIGUE 19675 0.0252
523 DYSGEUSIA 1875 0.0252
524 CONTRAINDICATED PRODUCT ADMINISTERED 764 0.0252
525 SKIN DISCOLOURATION 1159 0.0252
526 WEIGHT FLUCTUATION 263 0.0251
527 ORAL CANDIDIASIS 331 0.0251
528 NIGHTMARE 869 0.0251
529 RASH PRURITIC 1361 0.0251
530 GENERAL PHYSICAL HEALTH DETERIORATION 2901 0.0250
531 MUCOSAL INFLAMMATION 655 0.0250
532 CLOSTRIDIUM DIFFICILE INFECTION 546 0.0250
533 CHOKING 488 0.0250
534 ABDOMINAL DISTENSION 2609 0.0250
535 MIDDLE INSOMNIA 465 0.0249
536 PANCYTOPENIA 1391 0.0249
537 PRODUCT PRESCRIBING ERROR 592 0.0248
538 DYSPHONIA 1452 0.0248
539 HOT FLUSH 1865 0.0247
540 EOSINOPHIL COUNT INCREASED 206 0.0247
541 PHOTOSENSITIVITY REACTION 408 0.0247
542 BACTERIAL INFECTION 459 0.0246
543 SNEEZING 551 0.0245
544 NECK PAIN 1371 0.0245
545 AFFECT LABILITY 236 0.0245
546 OBESITY 390 0.0245
547 DIABETES MELLITUS 1860 0.0244
548 PNEUMOCYSTIS JIROVECII PNEUMONIA 245 0.0244
549 LYMPHOCYTE COUNT DECREASED 431 0.0244
550 PRURITUS GENERALISED 526 0.0243
551 TUMOUR LYSIS SYNDROME 214 0.0243
552 RHINORRHOEA 1568 0.0242
553 AMNESIA 1574 0.0242
554 BRAIN FOG 379 0.0242
555 FACIAL PARALYSIS 206 0.0241
556 DISSEMINATED INTRAVASCULAR COAGULATION 340 0.0241
557 NASAL CONGESTION 1419 0.0241
558 KIDNEY INFECTION 473 0.0241
559 INTERVERTEBRAL DISC PROTRUSION 525 0.0240
560 ASTHMA 2713 0.0240
561 OSTEOPENIA 364 0.0240
562 OROPHARYNGEAL PAIN 2218 0.0239
563 OSTEOPOROSIS 985 0.0239
564 STEVENS-JOHNSON SYNDROME 531 0.0239
565 VOMITING 11221 0.0238
566 POISONING DELIBERATE 226 0.0238
567 COLITIS 903 0.0238
568 SPLENOMEGALY 279 0.0238
569 GLYCOSYLATED HAEMOGLOBIN INCREASED 600 0.0237
570 DIABETIC KETOACIDOSIS 571 0.0237
571 LIMB INJURY 645 0.0237
572 METASTASES TO LUNG 274 0.0237
573 PARAESTHESIA ORAL 342 0.0237
574 VITREOUS FLOATERS 233 0.0237
575 HEPATIC ENCEPHALOPATHY 221 0.0237
576 BLINDNESS UNILATERAL 334 0.0237
577 JOINT RANGE OF MOTION DECREASED 317 0.0236
578 SKIN HAEMORRHAGE 350 0.0236
579 EYE HAEMORRHAGE 315 0.0236
580 BURSITIS 286 0.0235
581 LUNG DISORDER 1155 0.0235
582 MULTI-ORGAN FAILURE 407 0.0235
583 ABDOMINAL PAIN UPPER 4845 0.0235
584 ARTHRALGIA 9778 0.0235
585 CEREBROVASCULAR ACCIDENT 3981 0.0235
586 RETINAL DETACHMENT 216 0.0235
587 EAR DISCOMFORT 241 0.0235
588 JOINT INJURY 501 0.0234
589 MUSCULOSKELETAL STIFFNESS 2054 0.0234
590 MALAISE 10257 0.0234
591 THYROID DISORDER 360 0.0233
592 HIP FRACTURE 749 0.0233
593 BRONCHITIS 1719 0.0232
594 SLEEP DISORDER 1634 0.0231
595 NIGHT SWEATS 745 0.0231
596 BLOOD BILIRUBIN INCREASED 624 0.0231
597 PHARYNGEAL OEDEMA 354 0.0230
598 TOOTH INFECTION 303 0.0230
599 SEPTIC SHOCK 1000 0.0230
600 THROAT IRRITATION 1028 0.0229
601 BLOOD CHOLESTEROL INCREASED 1067 0.0229
602 TOOTH ABSCESS 233 0.0229
603 SWELLING 2139 0.0228
604 FEEDING DISORDER 463 0.0228
605 BLOOD TRIGLYCERIDES INCREASED 403 0.0228
606 POOR VENOUS ACCESS 236 0.0228
607 STOMATITIS 1380 0.0227
608 EXOSTOSIS 207 0.0226
609 FACE OEDEMA 382 0.0226
610 PNEUMOTHORAX 358 0.0226
611 BRAIN OEDEMA 285 0.0225
612 EYELID OEDEMA 262 0.0225
613 COLD SWEAT 397 0.0225
614 SEDATION 589 0.0225
615 SOMNOLENCE 4517 0.0224
616 BLOOD GLUCOSE FLUCTUATION 245 0.0223
617 PULMONARY THROMBOSIS 243 0.0223
618 DEMENTIA 622 0.0222
619 MALIGNANT MELANOMA 298 0.0222
620 INFLAMMATION 1147 0.0222
621 CARPAL TUNNEL SYNDROME 311 0.0222
622 PYREXIA 7668 0.0221
623 BLADDER DISORDER 220 0.0221
624 OSTEOMYELITIS 401 0.0221
625 MOVEMENT DISORDER 711 0.0221
626 JOINT DISLOCATION 234 0.0221
627 LIGAMENT SPRAIN 218 0.0220
628 COLON CANCER 328 0.0220
629 HEPATOCELLULAR INJURY 312 0.0220
630 HYPERSOMNIA 629 0.0219
631 ANKLE FRACTURE 338 0.0218
632 DIARRHOEA HAEMORRHAGIC 204 0.0218
633 COMA 1038 0.0218
634 METASTASES TO LIVER 383 0.0218
635 INFUSION SITE PAIN 280 0.0217
636 PARAESTHESIA 3418 0.0217
637 FEELING HOT 1330 0.0217
638 COVID-19 3803 0.0217
639 INFLUENZA 2413 0.0216
640 HYPERHIDROSIS 2784 0.0216
641 MASS 302 0.0216
642 RETCHING 460 0.0216
643 INSOMNIA 5739 0.0215
644 TOOTH FRACTURE 237 0.0215
645 JOINT STIFFNESS 563 0.0214
646 TENDONITIS 332 0.0214
647 NAUSEA 16946 0.0214
648 ACCIDENTAL OVERDOSE 783 0.0214
649 TYPE 2 DIABETES MELLITUS 720 0.0214
650 NEUROPATHY PERIPHERAL 2033 0.0214
651 PHARYNGITIS 264 0.0213
652 THROMBOCYTOPENIA 2377 0.0212
653 MUSCLE TIGHTNESS 344 0.0212
654 APHONIA 296 0.0212
655 ERUCTATION 410 0.0212
656 SUDDEN DEATH 224 0.0211
657 NODULE 276 0.0211
658 INTESTINAL OBSTRUCTION 796 0.0211
659 PULMONARY EMBOLISM 2006 0.0211
660 MYOCARDITIS 241 0.0210
661 CANDIDA INFECTION 355 0.0210
662 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 357 0.0210
663 DEPRESSED MOOD 1109 0.0210
664 GAIT INABILITY 701 0.0210
665 RESPIRATORY ARREST 578 0.0209
666 TREMOR 3470 0.0209
667 MEMORY IMPAIRMENT 2868 0.0209
668 CARDIOMYOPATHY 308 0.0208
669 VISUAL IMPAIRMENT 2582 0.0208
670 RESTLESSNESS 762 0.0208
671 DEEP VEIN THROMBOSIS 1351 0.0208
672 TREATMENT NONCOMPLIANCE 1137 0.0208
673 HERPES ZOSTER 1193 0.0207
674 HEADACHE 13016 0.0207
675 NEPHROLITHIASIS 952 0.0207
676 TOOTH DISORDER 461 0.0207
677 VISION BLURRED 2841 0.0207
678 LIVER FUNCTION TEST INCREASED 444 0.0207
679 IMPAIRED WORK ABILITY 442 0.0207
680 RESTLESS LEGS SYNDROME 376 0.0207
681 BODY TEMPERATURE INCREASED 421 0.0206
682 PERITONITIS BACTERIAL 208 0.0206
683 CYTOPENIA 252 0.0206
684 HYPOAESTHESIA 3080 0.0206
685 DRUG LEVEL DECREASED 209 0.0205
686 LIVER DISORDER 907 0.0204
687 RASH MACULAR 713 0.0204
688 PRODUCT ADMINISTRATION ERROR 412 0.0204
689 SPEECH DISORDER 1068 0.0204
690 EYE INFECTION 230 0.0203
691 HEPATITIS 520 0.0203
692 POISONING 255 0.0203
693 APATHY 296 0.0203
694 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 522 0.0203
695 EAR PAIN 394 0.0202
696 PANCREATITIS 1071 0.0202
697 INTESTINAL PERFORATION 226 0.0201
698 BURNING SENSATION 1409 0.0201
699 INTENTIONAL PRODUCT MISUSE 1759 0.0201
700 PRURITUS 7713 0.0201
701 LACRIMATION INCREASED 606 0.0200
702 ANXIETY 5708 0.0200
703 BLOOD GLUCOSE ABNORMAL 370 0.0200
704 POST PROCEDURAL HAEMORRHAGE 233 0.0200
705 DEVICE RELATED INFECTION 308 0.0200
706 FOETAL EXPOSURE DURING PREGNANCY 1626 0.0200
707 FLUSHING 2033 0.0200
708 BREAST PAIN 213 0.0200
709 ORAL HERPES 389 0.0199
710 WOUND 556 0.0199
711 TRANSAMINASES INCREASED 442 0.0199
712 CHILLS 2327 0.0198
713 DELUSION 308 0.0198
714 SENSORY DISTURBANCE 318 0.0198
715 HERNIA 383 0.0198
716 SYNOVITIS 357 0.0198
717 WHITE BLOOD CELL COUNT DECREASED 2141 0.0197
718 SCAB 225 0.0197
719 GASTROINTESTINAL PAIN 217 0.0197
720 MYOCARDIAL INFARCTION 3440 0.0197
721 LIVER INJURY 484 0.0197
722 PRESCRIBED UNDERDOSE 393 0.0197
723 LUNG INFECTION 306 0.0197
724 CONDITION AGGRAVATED 5977 0.0196
725 ARTHROPATHY 1091 0.0196
726 TENDON RUPTURE 242 0.0196
727 NASOPHARYNGITIS 3600 0.0195
728 GENERALISED TONIC-CLONIC SEIZURE 323 0.0195
729 NERVE INJURY 217 0.0195
730 MACULAR DEGENERATION 233 0.0195
731 ORAL DISCOMFORT 271 0.0195
732 POST PROCEDURAL COMPLICATION 374 0.0195
733 SARS-COV-2 TEST POSITIVE 257 0.0194
734 NEUTROPHIL COUNT DECREASED 793 0.0194
735 GASTROENTERITIS VIRAL 351 0.0194
736 UPPER LIMB FRACTURE 387 0.0194
737 BLOOD GLUCOSE INCREASED 3656 0.0194
738 QUALITY OF LIFE DECREASED 260 0.0194
739 EYE SWELLING 720 0.0193
740 SKIN INFECTION 217 0.0193
741 DRUG INTOLERANCE 1865 0.0193
742 BONE PAIN 1130 0.0193
743 DERMATITIS 404 0.0193
744 IMMUNODEFICIENCY 287 0.0192
745 ALOPECIA 3778 0.0192
746 PAIN 11793 0.0192
747 FEELING ABNORMAL 4597 0.0192
748 LYMPHADENOPATHY 677 0.0191
749 DEAFNESS 499 0.0191
750 POLYNEUROPATHY 228 0.0190
751 PARALYSIS 272 0.0190
752 THERAPY NON-RESPONDER 853 0.0190
753 BLOOD GLUCOSE DECREASED 911 0.0190
754 INCREASED APPETITE 362 0.0189
755 CYST 235 0.0189
756 CAESAREAN SECTION 220 0.0189
757 HEPATIC CYTOLYSIS 240 0.0188
758 EYE PAIN 1062 0.0188
759 INFUSION RELATED REACTION 1247 0.0188
760 WOUND INFECTION 206 0.0188
761 LYMPHOPENIA 266 0.0188
762 SINUSITIS 1920 0.0187
763 FOOT FRACTURE 355 0.0187
764 PHOTOPHOBIA 352 0.0187
765 HEPATIC ENZYME INCREASED 1275 0.0187
766 BONE DISORDER 340 0.0186
767 UPPER RESPIRATORY TRACT INFECTION 862 0.0186
768 WEIGHT INCREASED 4177 0.0186
769 NERVOUSNESS 973 0.0186
770 OCULAR DISCOMFORT 209 0.0186
771 SCAR 318 0.0186
772 RESPIRATORY DISORDER 555 0.0185
773 NEUROTOXICITY 325 0.0185
774 MALIGNANT NEOPLASM PROGRESSION 1896 0.0185
775 PERITONITIS 383 0.0185
776 BEDRIDDEN 243 0.0185
777 RASH ERYTHEMATOUS 883 0.0185
778 WRIST FRACTURE 221 0.0184
779 GASTRIC HAEMORRHAGE 212 0.0184
780 HEPATOTOXICITY 410 0.0184
781 RASH 8020 0.0184
782 INTENTIONAL DOSE OMISSION 524 0.0184
783 SYSTEMIC LUPUS ERYTHEMATOSUS 650 0.0183
784 DISEASE RECURRENCE 870 0.0183
785 BACK DISORDER 297 0.0182
786 DYSKINESIA 741 0.0182
787 DEPRESSION 4143 0.0182
788 PLASMA CELL MYELOMA 710 0.0182
789 THROMBOSIS 1463 0.0182
790 NEOPLASM 209 0.0182
791 SPINAL FRACTURE 363 0.0181
792 DISCOMFORT 1105 0.0181
793 MUSCLE RIGIDITY 216 0.0180
794 ECZEMA 944 0.0180
795 GASTROINTESTINAL DISORDER 1615 0.0180
796 TOOTHACHE 326 0.0180
797 ANAPHYLACTIC REACTION 994 0.0180
798 VIRAL INFECTION 598 0.0180
799 HEPATIC CIRRHOSIS 337 0.0179
800 CYANOSIS 282 0.0179
801 SKIN DISORDER 598 0.0179
802 HEPATIC FAILURE 540 0.0179
803 SKIN CANCER 385 0.0179
804 RASH GENERALISED 463 0.0179
805 ABDOMINAL PAIN LOWER 452 0.0179
806 THERAPY CESSATION 917 0.0178
807 GLOSSODYNIA 397 0.0177
808 CYTOKINE RELEASE SYNDROME 354 0.0176
809 OVERDOSE 3793 0.0176
810 AGITATION 1290 0.0175
811 THERAPY INTERRUPTED 1255 0.0175
812 STAPHYLOCOCCAL INFECTION 579 0.0175
813 MUSCULOSKELETAL DISORDER 334 0.0175
814 FEMUR FRACTURE 542 0.0175
815 MIGRAINE 1659 0.0174
816 CYTOMEGALOVIRUS INFECTION 287 0.0173
817 SKIN EXFOLIATION 1453 0.0172
818 PRODUCT DOSE OMISSION 1123 0.0172
819 EPILEPSY 525 0.0172
820 BRONCHOSPASM 245 0.0172
821 CARDIAC DISORDER 1606 0.0171
822 RESPIRATORY DEPRESSION 209 0.0170
823 ABSCESS 271 0.0170
824 HYPOAESTHESIA ORAL 256 0.0170
825 EYE DISORDER 558 0.0170
826 SPINAL OPERATION 209 0.0169
827 DRUG TOXICITY 231 0.0169
828 DERMATITIS ALLERGIC 213 0.0169
829 PRODUCT SUBSTITUTION ISSUE 973 0.0169
830 FEELING JITTERY 322 0.0169
831 RHEUMATOID ARTHRITIS 1912 0.0168
832 OFF LABEL USE 14736 0.0168
833 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 288 0.0168
834 KNEE ARTHROPLASTY 353 0.0167
835 SEIZURE 1933 0.0167
836 ABASIA 413 0.0167
837 COLITIS ULCERATIVE 746 0.0167
838 HIP ARTHROPLASTY 255 0.0166
839 PRODUCT TASTE ABNORMAL 225 0.0166
840 LABORATORY TEST ABNORMAL 488 0.0165
841 FRACTURE 313 0.0165
842 VISUAL ACUITY REDUCED 548 0.0165
843 INFECTION 2379 0.0164
844 ERYTHEMA 3378 0.0164
845 LEUKOPENIA 821 0.0164
846 FUNGAL INFECTION 547 0.0164
847 DISEASE PROGRESSION 1936 0.0163
848 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1147 0.0161
849 CONJUNCTIVITIS 298 0.0160
850 THROAT TIGHTNESS 432 0.0160
851 DRY EYE 797 0.0160
852 INTRAOCULAR PRESSURE INCREASED 204 0.0159
853 METASTASES TO BONE 261 0.0159
854 IMPAIRED HEALING 522 0.0159
855 HAEMORRHAGE 1660 0.0159
856 GALLBLADDER DISORDER 282 0.0158
857 HYPOACUSIS 680 0.0158
858 EXPOSURE DURING PREGNANCY 981 0.0158
859 ANAPHYLACTIC SHOCK 403 0.0156
860 NEUTROPENIA 2124 0.0156
861 OSTEONECROSIS OF JAW 386 0.0156
862 PSORIASIS 2027 0.0155
863 HALLUCINATION, AUDITORY 245 0.0154
864 MATERNAL EXPOSURE DURING PREGNANCY 1365 0.0153
865 DRY SKIN 2039 0.0153
866 GASTRIC DISORDER 523 0.0152
867 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2733 0.0151
868 NEOPLASM PROGRESSION 525 0.0151
869 MENTAL IMPAIRMENT 363 0.0150
870 EYE IRRITATION 862 0.0150
871 ILLNESS 1541 0.0149
872 ABNORMAL DREAMS 413 0.0149
873 PRODUCT DOSE OMISSION IN ERROR 422 0.0149
874 INFLUENZA LIKE ILLNESS 1226 0.0149
875 CARDIOVASCULAR DISORDER 374 0.0147
876 PROCEDURAL PAIN 406 0.0146
877 OCULAR HYPERAEMIA 694 0.0146
878 PRODUCT DISPENSING ERROR 318 0.0146
879 MYELODYSPLASTIC SYNDROME 210 0.0145
880 PRODUCT USE COMPLAINT 227 0.0144
881 LOWER LIMB FRACTURE 274 0.0142
882 FIBROMYALGIA 346 0.0142
883 HYPERSENSITIVITY 2636 0.0142
884 FEAR 381 0.0142
885 ROAD TRAFFIC ACCIDENT 592 0.0141
886 ACTIVITIES OF DAILY LIVING IMPAIRED 280 0.0141
887 UNEVALUABLE EVENT 1068 0.0141
888 BONE MARROW FAILURE 286 0.0141
889 ADVERSE DRUG REACTION 1260 0.0140
890 PRESCRIBED OVERDOSE 269 0.0139
891 IRRITABLE BOWEL SYNDROME 298 0.0139
892 PRODUCT USE ISSUE 2607 0.0139
893 PSORIATIC ARTHROPATHY 562 0.0138
894 PANIC ATTACK 503 0.0138
895 LYMPHOMA 213 0.0138
896 PRODUCT USE IN UNAPPROVED INDICATION 3415 0.0138
897 MENTAL DISORDER 599 0.0138
898 URTICARIA 2300 0.0137
899 PRODUCT PHYSICAL ISSUE 275 0.0136
900 DRUG PRESCRIBING ERROR 261 0.0136
901 EAR INFECTION 361 0.0136
902 HOSPITALISATION 2072 0.0135
903 THINKING ABNORMAL 250 0.0134
904 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 733 0.0133
905 SKIN FISSURES 257 0.0131
906 INCORRECT PRODUCT ADMINISTRATION DURATION 283 0.0130
907 MOOD ALTERED 355 0.0130
908 NERVOUS SYSTEM DISORDER 402 0.0129
909 THERAPEUTIC PRODUCT EFFECT DECREASED 576 0.0128
910 MANIA 210 0.0128
911 PARANOIA 220 0.0127
912 EXTRAPYRAMIDAL DISORDER 316 0.0127
913 PSYCHOMOTOR HYPERACTIVITY 211 0.0127
914 TOOTH LOSS 256 0.0123
915 PRODUCT DOSE OMISSION ISSUE 3608 0.0123
916 ILL-DEFINED DISORDER 745 0.0123
917 SURGERY 708 0.0121
918 PRODUCT AVAILABILITY ISSUE 272 0.0119
919 DRUG INEFFECTIVE 15737 0.0119
920 DRUG DOSE OMISSION 1972 0.0119
921 THERAPEUTIC RESPONSE UNEXPECTED 535 0.0119
922 SUICIDAL IDEATION 1075 0.0117
923 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 834 0.0117
924 PSYCHOTIC DISORDER 344 0.0116
925 THERAPEUTIC RESPONSE DECREASED 705 0.0116
926 LUNG NEOPLASM MALIGNANT 477 0.0116
927 AGGRESSION 575 0.0115
928 DRUG EFFECT INCOMPLETE 417 0.0115
929 DEATH 9741 0.0113
930 INJECTION SITE MASS 416 0.0112
931 NEEDLE ISSUE 326 0.0112
932 PRODUCT PRESCRIBING ISSUE 241 0.0111
933 THERAPEUTIC RESPONSE SHORTENED 366 0.0110
934 ABNORMAL BEHAVIOUR 437 0.0110
935 EMOTIONAL DISTRESS 1307 0.0108
936 EMOTIONAL DISORDER 330 0.0107
937 PRODUCT QUALITY ISSUE 1406 0.0103
938 ANGER 350 0.0103
939 EXPIRED PRODUCT ADMINISTERED 343 0.0103
940 UNDERDOSE 751 0.0103
941 INTENTIONAL DRUG MISUSE 210 0.0100
942 CONVULSION 570 0.0100
943 IRRITABILITY 598 0.0099
944 INCORRECT DOSE ADMINISTERED 2255 0.0099
945 DRUG ADMINISTRATION ERROR 303 0.0099
946 BONE DENSITY DECREASED 307 0.0098
947 CRYING 354 0.0097
948 INCORRECT DRUG ADMINISTRATION DURATION 271 0.0096
949 DRUG RESISTANCE 245 0.0095
950 WITHDRAWAL SYNDROME 398 0.0095
951 APPLICATION SITE PRURITUS 214 0.0094
952 DRUG EFFECT DECREASED 506 0.0094
953 NEOPLASM MALIGNANT 626 0.0094
954 ADVERSE EVENT 856 0.0093
955 INJURY 645 0.0092
956 MOOD SWINGS 287 0.0090
957 DRUG EXPOSURE DURING PREGNANCY 299 0.0088
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 315 0.0087
959 TREATMENT FAILURE 713 0.0086
960 PANCREATIC CARCINOMA 245 0.0085
961 INJECTION SITE BRUISING 656 0.0082
962 INJECTION SITE HAEMORRHAGE 656 0.0082
963 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1636 0.0081
964 EXTRA DOSE ADMINISTERED 326 0.0080
965 DERMATITIS ATOPIC 423 0.0080
966 DEVICE ISSUE 688 0.0077
967 VAGINAL HAEMORRHAGE 331 0.0076
968 DEVICE MALFUNCTION 533 0.0076
969 ACNE 571 0.0075
970 TARDIVE DYSKINESIA 206 0.0073
971 INJECTION SITE PRURITUS 478 0.0071
972 OSTEONECROSIS 234 0.0071
973 DRUG ABUSE 588 0.0071
974 INJECTION SITE PAIN 2126 0.0069
975 INJECTION SITE SWELLING 530 0.0069
976 MULTIPLE SCLEROSIS RELAPSE 470 0.0069
977 SKIN IRRITATION 306 0.0067
978 SKIN BURNING SENSATION 477 0.0067
979 MULTIPLE SCLEROSIS 300 0.0063
980 PROSTATE CANCER 497 0.0062
981 INJECTION SITE ERYTHEMA 742 0.0060
982 PRODUCT ADHESION ISSUE 212 0.0059
983 DEVICE DISLOCATION 256 0.0059
984 INJECTION SITE REACTION 393 0.0057
985 NO ADVERSE EVENT 947 0.0052
986 BREAST CANCER 486 0.0052
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 239 0.0051
988 RENAL CANCER 240 0.0050
989 ACCIDENTAL EXPOSURE TO PRODUCT 471 0.0046
990 DRUG DOSE OMISSION BY DEVICE 308 0.0039
991 BLADDER CANCER 231 0.0039
992 DRUG WITHDRAWAL SYNDROME 333 0.0038
993 PRODUCT STORAGE ERROR 321 0.0037
994 DRUG DEPENDENCE 274 0.0017